NHS’ Therapeutic Apheresis Services (TAS) provide life-saving and life-enhancing therapeutic apheresis services to adults and children in the UK. TAS services are delivered across England and North Wales from eight therapeutic apheresis units which operate an outpatient model for non-acute patients. TAS supports a range of clinical specialties including haematology, oncology, nephrology, neurology and rheumatology. [...]
We're delighted that our chairs have been put to work for health and healing in Macclesfield. Below are excerpts from the original press release: "The Christie at Macclesfield benefits patients from Cheshire, the High Peak area of Derbyshire and parts of North Staffordshire who would normally have to travel long distances for their cancer treatment [...]
Digiterm Ltd. is proudly celebrating its 30th anniversary of providing excellent products and service. Our commitment to providing state of the art products and service allowed us to establish unique relationships with our long term customers, who are the main reason why we were able to continue over the years. We are grateful to [...]
Dun & Bradstreet, the international provider of business information and company ratings classifies the financial stability and business reliability of all enterprises based on a proven system, that has been designed by international experts, and whose operation is consistently measured. This is how our company has been chosen as one of the enterprises with the steadiest financial standing.
Being active on the market of medical devices for 30 years, Digiterm Ltd. is committed to comply all the highest requirements of healthcare applications. As you are aware, as of the end of May 2021 a new Medical Device Regulation is to be introduced by the European Commission under the number (EU) 2017/745 (MDR).